Table 1 Experimental designs showing the several formulations administered to the various experimental groups
Experimental group | Formulations | Days administered |
|---|---|---|
Group 1 (3DHBV) | 2 µg of rHBsAg (3 doses) | 1, 15 and 22 |
Group 2 (2DHBV) | 2 µg of rHBsAg (2 doses) | 1, 22 |
Group 3 (2DHBV + ESM) | 2 µg rHBsAg + 300 µg ESM (2 doses) | 1 and 22 |
Group 4 (3DESM) | 300 µg ESM (2 doses) | 1 and 22 |
Group 5 (3DControl) | Normal saline | 1, 15 and 22 |